Table 3.

Use of mould-active anti-fungal drugs after alloSCT in the subgroup of patients with available comprehensive information on drug use.

	IA pre alloSCT		Total (N = 1152)
	No (N = 1083)	Yes (N = 69)
	N (%)	N (%)	N (%)
Any anti-mould drug given day 0- day +99
No	398 (36.7)	8 (11.6)	406 (35.2)
Yes	685 (63.3)	61 (88.4)	746 (64.8)
Posaconazole given day 0 to +99
No	785 (72.5)	45 (65.2)	830 (72.0)
Yes	298 (27.5)	24 (34.8)	322 (28.0)
Voriconazole given day 0–day +99
No	841 (77.7)	42 (60.9)	883 (76.6)
Yes	242 (22.3)	27 (39.1)	269 (23.4)
Ambisome given day 0–day +99
No	877 (81.0)	46 (66.7)	923 (80.1)
Yes	206 (19.0)	23 (33.3)	229 (19.9)
Echinocandin given day 0–day +99
No	937 (86.5)	61 (88.4)	998 (86.6)
Yes	146 (13.5)	8 (11.6)	154 (13.4)
Amphotericin given day 0–day +99
No	1027 (94.8)	69 (100.0)	1096 (95.1)
Yes	56 (5.2)	0 (0.0)	56 (4.9)
Isavuconazole given day 0–day +99
No	1054 (97.3)	65 (94.2)	1119 (97.1)
Yes	29 (2.7)	4 (5.8)	33 (2.9)
	N = 924	N = 56	N = 980
Any anti-mould drug given day +100–day +365
No	520 (56.3)	19 (33.9)	539 (55.0)
Yes	404 (43.7)	37 (66.1)	441 (45.0)
Posaconazole given day +100–day +365
No	720 (77.9)	46 (82.1)	766 (78.2)
Yes	204 (22.1)	10 (17.9)	214 (21.8)
Voriconazole given day +100–day +365
No	765 (82.8)	37 (66.1)	802 (81.8)
Yes	159 (17.2)	19 (33.9)	178 (18.2)
Ambisome given day +100–day +365
No	833 (90.2)	42 (75.0)	875 (89.3)
Yes	91 (9.8)	14 (25.0)	105 (10.7)
Echinocandin given day +100–day +365
No	863 (93.4)	51 (91.1)	914 (93.3)
Yes	61 (6.6)	5 (8.9)	66 (6.7)
Amphotericin given day +100–day +365
No	902 (97.6)	56 (100.0)	958 (97.8)
Yes	22 (2.4)	0 (0.0)	22 (2.2)
Isavuconazole given day +100–day +365
No	897 (97.1)	52 (92.9)	949 (96.8)
Yes	27 (2.9)	4 (7.1)	31 (3.2)